InCarda at San Francisco Business Times – Bay Area Biotech Forum

May 23, 2018 – San Francisco, CA

At the SF Business Times Bay Area Biotech Forum, InCarda’s Dr. Grace Colon presented a company update to investors where she discussed the clinical challenges of Atrial Fibrillation and InCarda’s novel approach to treating it called, InRhythm (oral flecainide for inhalation).   Moderated by Bay Area reporter, Ron Leuty, the conference provided a forum to introduce local up-and-coming life sciences companies looking to change the world.


Back to News & Updates